Funded Startups in Milwaukee
Milwaukee’s disclosed round sizes are anchored by a single outlier: Neutral raised $133M on 2025-01-06, dwarfing the rest of the largest disclosed figures,…
Milwaukee’s disclosed round sizes are anchored by a single outlier: Neutral raised $133M on 2025-01-06, dwarfing the rest of the largest disclosed figures, where the next-largest is $43M (Doral, 2025-05-22). Beyond that top tier, disclosed amounts cluster heavily in the single-digit to low-teens range (e.g., Advanced Ionics $7M on 2025-01-08; Neostella $11M on 2025-06-05; Penrod $8M on 2022-02-03), with the smallest disclosed being $10K (Pawcasso on 2023-04-10).
The page also shows a clear temporal concentration: many of the most recent entries close in 2025–2026 (e.g., Estrigenix Therapeutics $2M on 2026-07-21 and Rivermark Medical $20M on 2026-05-13), while the oldest shown closes on 2020-11-23 (Socialeads $2M). Sector-wise, Health Care and Financial Services both recur, and “Series Unknown” is prominent across the listing (including undisclosed-size rounds such as BiaCure Therapies on 2026-06-08 and ConsensioHealth on 2026-04-23), indicating that deal sizing and stage labeling are sometimes incomplete even when amounts are disclosed.
Most recent rounds
46 shownRelated listings
Frequently asked
Which deal stands out by disclosed amount, and how far ahead is it of the next-largest disclosed round?
Neutral’s disclosed $133M (2025-01-06) is the largest figure on the page, and it is significantly ahead of the next-largest disclosed amount: Doral’s $43M (2025-05-22).
How concentrated are the disclosed rounds by time among the most recent entries shown?
Several of the larger disclosed rounds cluster in the 2025–2026 window: Rivermark Medical disclosed $20M on 2026-05-13, Neostella disclosed $11M on 2025-06-05, and Doral disclosed $43M on 2025-05-22. Earlier years also contribute material rounds, such as SpotHopper’s $12M (2023-06-13) and Penrod’s $8M (2022-02-03).
Are there stage-label patterns, especially around missing stage classifications?
“Series Unknown” appears repeatedly across the list, including entries with undisclosed amounts like BiaCure Therapies (2026-06-08) and ConsensioHealth (2026-04-23). Among disclosed amounts in 2025–2026, “Series Unknown” coexists with clearly labeled rounds (e.g., N-Zyme Biomedical Inc. Series A for $5M on 2026-07-21, and Rivermark Medical Series D for $20M on 2026-05-13).
Do any sectors appear often enough to suggest a concentration in Milwaukee’s funded activity on this page?
Health Care is a recurring sector across multiple entries (e.g., Estrigenix Therapeutics 2026-07-21 $2M; Rivermark Medical 2026-05-13 $20M; Sift Healthcare 2024-05-09 $20M). Financial Services also shows up more than once (e.g., VRC 2026-05-11 $900K; Neostella 2025-06-05 $11M; Ideawake 2022-02-03 $1M).
Which entries represent meaningful outliers at the low end versus the largest disclosed figures?
At the low end, the smallest disclosed amount is $10K for Pawcasso (2023-04-10), which contrasts sharply with the top disclosed amounts such as Neutral’s $133M (2025-01-06) and Doral’s $43M (2025-05-22).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.